Sep 16 2013
Corindus Vascular Robotics, a leading developer of precision vascular robotics, won the Massachusetts Technology Leadership Council’s Award for the 2013 Innovative Technology of the Year - Robotics last night at the Council’s 16th annual Awards Gala.
More than 700 senior executives were present at the Westin Waterfront for Boston’s premier annual tech awards event that showcases and celebrates the depth and breadth of the state’s vibrant technology ecosystem.
“We are honored to award Corindus with the 2013 Innovative Technology of the Year for Robotics,” said Tom Hopcroft, President and CEO of MassTLC. “Corindus’ leadership is a shining example of what it takes to keep the Commonwealth’s tech sector growing and thriving. It’s our pleasure to recognize and encourage such excellence. Congratulations to Corindus and the strong team behind their success.”
“Using robotics to set new standards of safety, precision and accuracy will greatly benefit patients of medical procedures, such as angioplasties,” said David Handler, president and CEO of Corindus Vascular Robotics. “We are working diligently every day to deliver a future where better outcomes in healthcare go hand-in-hand with innovation and are proud to have our robotics recognized by MassTLC as we continue with our mission.”
The first and only FDA-cleared technology that enables precise, robotic-assisted angioplasties, Corindus’ CorPath 200 System is utilized to open blockages within arteries and restore blood flow in patients with coronary artery disease. During a CorPath angioplasty procedure, the interventional cardiologist sits in a radiation shielded interventional cockpit, where he is able to advance stents and guidewires via a joystick with millimeter by millimeter robotic precision. The CorPath enables precise measurement of the anatomy, which could potentially lead to better stent placements and improved clinical outcomes.
Source: http://www.corindus.com/